NCT03475264

Brief Summary

The MRI tools developed by the investigators are well positioned for assessing regional changes in lung structure and function in preterm children with bronchopulmonary dysplasia (BPD), in which airway limitation similar to asthma, alveolar simplification similar to emphysema and pulmonary vascular stunting are expected. To the investigator's knowledge, the combination of ultra short echo time (UTE) proton, pulmonary vascular proton and hyperpolarized 129Xe MRI have not yet been explored in BPD, either clinically or preclinically. The investigators propose that a comprehensive MRI examination may be useful from a diagnostic perspective, MRI of preterm children without BPD may reveal changes which are otherwise clinically 'silent' yet still place children at risk for future chronic lung disease in later life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 23, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2019

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

February 6, 2018

Last Update Submit

July 29, 2025

Conditions

Keywords

Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,

Outcome Measures

Primary Outcomes (1)

  • MRI ventilation and 1H MRI thoracic cavity volume and tissue density

    Ventilation defect percent (VDP) (%) will be generated for whole lung and individual lung slices using manual or semi-automated segmentation. For proton (1H) thoracic cavity images, the thoracic cavity volume (TCV) will be calculated by manual or semi-automated segmentation.

    2 years

Secondary Outcomes (2)

  • Apparent Diffusion Coefficients (ADC) and ADC maps

    2 years

  • Multiple breath washout testing:

    2 years

Study Arms (3)

Healthy

Healthy Participants

Diagnostic Test: Lung MRI

BPD cohort

Participants born prematurely with a diagnosis of BPD

Diagnostic Test: Lung MRI

Non-BPD cohort

Participants born prematurely without a diagnosis of BPD

Diagnostic Test: Lung MRI

Interventions

Lung MRIDIAGNOSTIC_TEST

Participants will be undergoing hyperpolarized xenon and proton lung MRI

BPD cohortHealthyNon-BPD cohort

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Healthy volunteers will be selected from the general population and the BPD and non-BPD cohorts will be selected from patients from clinics seen at the Hospital for Sick Children, Toronto

You may qualify if:

  • \- Children born pre-term at less than 28 weeks' gestation, currently aged 6-9 years, with and without BPD will be included.
  • need for oxygen at 36 weeks' postmenstrual age, which includes those with moderate-severe disease .
  • absence of any diagnosed pulmonary disease and term birth.

You may not qualify if:

  • known interstitial lung disease, congenital lung anomalies, cystic fibrosis, ciliary dysfunction, immunodeficiency, neuromuscular disease or structural heart disease, which may have associated pulmonary function tests (PFT) and/or MRI findings;
  • genetic syndromes which may have other associated structural lung anomalies;
  • any contraindications for MRI
  • severe neurosensory deficits which would prevent test completion;
  • viral or bacterial respiratory infection within 6 weeks will be excluded. For all three groups (healthy, preterm non-BPD and preterm BPD), we will exclude
  • those with congenital lung disease (i.e. Congenital diaphragmatic hernia (CDH), lung cysts) or non BPD acquired chronic lung disease as defined by need for any routine supplementary oxygen
  • if the participant has an MRI incompatible device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bio prosthetic, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

MeSH Terms

Conditions

Bronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Scientist

Study Record Dates

First Submitted

February 6, 2018

First Posted

March 23, 2018

Study Start

September 1, 2018

Primary Completion

October 8, 2019

Study Completion

October 8, 2019

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

IPD will not be shared with other researchers outside of the institutions

Locations